Cleared Special

K180438 - BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit (FDA 510(k) Clearance)

Mar 2018
Decision
28d
Days
Class 2
Risk

K180438 is an FDA 510(k) clearance for the BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit. This device is classified as a Devices Detecting Influenza A, B, And C Virus Antigens (Class II - Special Controls, product code PSZ).

Submitted by Bd (San Diego, US). The FDA issued a Cleared decision on March 20, 2018, 28 days after receiving the submission on February 20, 2018.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3328. An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection..

Submission Details

510(k) Number K180438 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 20, 2018
Decision Date March 20, 2018
Days to Decision 28 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PSZ - Devices Detecting Influenza A, B, And C Virus Antigens
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3328
Definition An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection.